Japan's Otsuka to buy Avanir for $3.5 billion ahead of patent cliff

(Reuters) - Japanese drugmaker Otsuka Holdings Co Ltd plans to buy U.S.-based Avanir Pharmaceuticals Inc for about $3.5 billion to expand its neurologic drug portfolio ahead of an expiration of a key drug patent.

from Reuters: Most Read Articles http://ift.tt/1yiBfRi http://www.reuters.com